loading

Share to:
facebook sharing button
whatsapp sharing button
linkedin sharing button
telegram sharing button
twitter sharing button
line sharing button
wechat sharing button
sharethis sharing button

Medlere M3 HPLC HbA1c Analyzer — Automated Clinical Glycated Hemoglobin Testing System

A fully automated ion-exchange HPLC system designed for precise glycated hemoglobin (HbA1c) measurement, reliable hemoglobin variant detection, and β-thalassemia screening in clinical laboratories.

Key Highlights:
  • High-precision HbA1c testing with CV ≤ 3%
  • Results available in under 2 minutes per sample
  • Minimal interference from common hemoglobin variants (HbS, HbC, HbD, HbE)
  • Supports β-Thalassemia screening
  • Direct sampling without cap removal
  • Compatible with venous and capillary blood (5 µL)
Availability:

PDF Export

  • M3

  • Medlere

  • HLC1001

Test Principle
Ion-exchange HPLC
Sample Type
Venous whole blood/ Capillary fingerstick
Sample Volume
5uL
Detection Time
<2 mins
Detection Range
4%-17%
Repeatability
CV≤ 3 %
Linearity
R²≥0.99
Dimension
535*310*535mm
Weight
<32kg
Connectivity
LIS/HIS/RS232

Accurate and Reliable HbA1c Measurement

Ion-exchange HPLC technology ensures high analytical accuracy and consistency, supporting confident clinical decision-making in diabetes management.

Standardized and Traceable Results

Meets NGSP and IFCC traceability standards for HbA1c testing, ensuring alignment with internationally recognized reference systems.

Proven Method Correlation

Demonstrates excellent correlation with reference HPLC methods (r² ≥ 0.99), supporting result reliability and clinical confidence.

Reduced Variant Interference

Designed to minimize the impact of common hemoglobin variants, improving result reliability in diverse patient populations.

Improved Laboratory Efficiency

Rapid turnaround time and automated workflow help streamline laboratory operations and increase daily testing capacity.

Expanded Diagnostic Capability

Supports β-Thalassemia screening alongside HbA1c measurement, providing additional clinical value in routine testing.

User-Friendly and Safe Operation

Direct sampling without removing tube caps enhances biosafety while simplifying workflow for laboratory staff.

Why Choose Ion-Exchange HPLC for HbA1c Testing?

Higher Specificity Compared to Immunoassays

Unlike immunoassay-based methods, HPLC separates hemoglobin fractions, reducing the risk of analytical interference.

Better Variant Detection Capability

HPLC enables identification of hemoglobin variants, supporting more accurate interpretation of HbA1c results.

Consistent and Standardized Results

Recognized as a reference method in many laboratories, HPLC provides high reproducibility and traceability.

Enhanced Clinical Confidence

By combining precision, specificity, and variant awareness, HPLC supports more reliable diabetes diagnosis and monitoring.

Clinical Laboratories

Suitable for medium to high-throughput laboratories requiring accurate and standardized HbA1c testing.

Diabetes Management Centers

Supports long-term glycemic monitoring with reliable and reproducible results for patient follow-up.

Preventive Health Screening

Ideal for routine health check-ups and early detection programs, enabling efficient large-scale screening.

Previous: 
Next: 

Who We Are

With the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
Contact Us
Address: 291 Brighton Road South Croydon United Kingdom Cr2 6Eq    E-mail: info@medlere.com    Tel.: +447565748991
The content on the Medlere website may showcase some of our forthcoming care offerings, which are currently under development. Please note that these offerings are subject to completion of the development process and may require regulatory authorization, clearance, or approval before they can be made available for commercial use.
@​2023 Medlere Limited. All Rights Reserved.